Leukine is a Intravenous; Subcutaneous Liquid in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Sargramostim.
Product ID | 0024-5844_ac281296-b49b-4f33-a16c-a83e60964713 |
NDC | 0024-5844 |
Product Type | Human Prescription Drug |
Proprietary Name | Leukine |
Generic Name | Sargramostim |
Dosage Form | Liquid |
Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
Marketing Start Date | 1996-12-01 |
Marketing End Date | 2021-12-30 |
Marketing Category | BLA / BLA |
Application Number | BLA103362 |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | SARGRAMOSTIM |
Active Ingredient Strength | 500 ug/mL |
Pharm Classes | Granulocyte Colony-Stimulating Factor [CS],Granulocyte-Macrophage Colony-Stimulating Factor [CS],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] |
NDC Exclude Flag | N |
Marketing Start Date | 1996-12-01 |
Marketing End Date | 2021-12-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103362 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1996-12-01 |
Marketing End Date | 2021-12-30 |
Marketing Category | BLA |
Application Number | BLA103362 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1996-12-01 |
Marketing End Date | 2021-12-30 |
Ingredient | Strength |
---|---|
SARGRAMOSTIM | 500 ug/mL |
SPL SET ID: | 04765fbf-f005-43aa-a628-5cc3d80f91e7 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0024-5843 | Leukine | SARGRAMOSTIM |
0024-5844 | Leukine | SARGRAMOSTIM |
71837-5843 | Leukine | SARGRAMOSTIM |
71837-5844 | Leukine | SARGRAMOSTIM |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LEUKINE 73831918 1653426 Live/Registered |
IMMUNEX CORPORATION 1989-10-13 |